Haleon plc (PINK:HLNCF) — Market Cap & Net Worth
Market Cap & Net Worth: Haleon plc (HLNCF)
Haleon plc (PINK:HLNCF) has a market capitalization of $45.87 Billion ($45.87 Billion) as of April 12, 2026. Listed on the PINK stock exchange, this USA-based company holds position #523 globally and #394 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Haleon plc's stock price $5.15 by its total outstanding shares 8906247075 (8.91 Billion).
Haleon plc Market Cap History: 2022 to 2025
Haleon plc's market capitalization history from 2022 to 2025. Data shows growth from $33.62 Billion to $45.87 Billion (17.14% CAGR).
Haleon plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Haleon plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.75x
Haleon plc's market cap is 3.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
29.21x
Haleon plc's market cap is 29.21 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $33.62 Billion | $10.86 Billion | $1.06 Billion | 3.10x | 31.71x |
| 2023 | $35.81 Billion | $11.30 Billion | $1.05 Billion | 3.17x | 34.14x |
| 2024 | $42.13 Billion | $11.23 Billion | $1.44 Billion | 3.75x | 29.21x |
Competitor Companies of HLNCF by Market Capitalization
Companies near Haleon plc in the global market cap rankings as of April 12, 2026.
Key companies related to Haleon plc by market ranking:
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #437 globally with a market cap of $53.26 Billion USD ( CN¥363.99 Billion CNY).
- Zoetis Inc (NYSE:ZTS): Ranked #454 globally with a market cap of $51.94 Billion USD.
- HANSOH PHARMAC. HD-00001 (F:3KY): Ranked #960 globally with a market cap of $23.69 Billion USD ( €20.26 Billion EUR).
- United Therapeutics Corporation (NASDAQ:UTHR): Ranked #1063 globally with a market cap of $21.42 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #437 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $53.26 Billion | CN¥57.06 |
| #454 | Zoetis Inc | NYSE:ZTS | $51.94 Billion | $117.86 |
| #960 | HANSOH PHARMAC. HD-00001 | F:3KY | $23.69 Billion | €4.14 |
| #1063 | United Therapeutics Corporation | NASDAQ:UTHR | $21.42 Billion | $571.73 |
Haleon plc Historical Marketcap From 2022 to 2025
Between 2022 and today, Haleon plc's market cap moved from $33.62 Billion to $ 45.87 Billion, with a yearly change of 17.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $45.87 Billion | +8.88% |
| 2024 | $42.13 Billion | +17.64% |
| 2023 | $35.81 Billion | +6.53% |
| 2022 | $33.62 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 2nd, 2026 the market cap of Haleon plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.87 Billion USD |
| MoneyControl | $45.87 Billion USD |
| MarketWatch | $45.87 Billion USD |
| marketcap.company | $45.87 Billion USD |
| Reuters | $45.87 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more